Breaking Finance News

Zacks Investment Research upgraded OMNOVA Solutions Inc. (NYSE:OMN) to Hold in a report released today.

Zacks Investment Research has upgraded OMNOVA Solutions Inc. (NYSE:OMN) to Hold in a report released on 11/30/2016.

Previously on Monday September 28, 2015, Deutsche Bank reported on OMNOVA Solutions Inc. (NYSE:OMN) reduced the target price from $9.00 to $7.00. At the time, this indicated a possible upside of 0%.

Yesterday OMNOVA Solutions Inc. (NYSE:OMN) traded 2.20% higher at $9.30. The company’s 50-day moving average is $8.27 and its 200-day moving average is $8.39. The last closing price is up 10.84% from the 200-day moving average, compared to the S&P 500 which has decreased -0.03% over the same time period. 126,791 shares of the stock traded hands, down from an average trading volume of 271,080

See Chart Below

OMNOVA Solutions Inc. (NYSE:OMN)

OMNOVA Solutions Inc. has a 52 week low of $4.37 and a 52 week high of $10.42 The company’s market cap is currently $0.

General Information About OMNOVA Solutions Inc. (NYSE:OMN)

OMNOVA Solutions Inc. (OMNOVA) is a provider of emulsion polymers, specialty chemicals and engineered surfaces for commercial, industrial and residential end uses. The Company operates in two segments: Performance Chemicals and Engineered Surfaces. OMNOVA Performance Chemicals segment produces a range of emulsion polymers and specialty chemicals based primarily on styrene butadiene (SB), styrene butadiene acrylonitrile (SBA), styrene butadiene vinyl pyridine, nitrile butadiene (NBR), polyvinyl acetate, acrylic, styrene acrylic, vinyl acrylic, glyoxal, fluorochemical and bio-based chemistries. The Company's Engineered Surfaces segment develops, designs, produces and markets a line of functional and decorative surfacing products, including coated fabrics, vinyl, paper and specialty laminates, and performance films. It operates production facilities in the United States, Europe, China and India.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *